Afif Yaacob

The Impact of Achieving Sustained Viral Response with Direct Antiviral Agents in in HCV/HIV Co-infected Patients.

Grace Haj, Nemer Sayed Ahmad, Roni Nasser, Fadi Abu Baker et autres

BACKGROUND: Co-infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) affects approximately 2.2 million people globally and is associated with accelerated liver disease progression, increased morbidity, and reduced quality of life (QoL). While direct-acting antivirals (DAAs) have revolutionized HCV treatment …

il (code pays fourni par la source)

Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term

Mahmoud Atamla, Johad Khoury, Ihab Dabbah, Rimma Kramsky et autres

INTRODUCTION: Direct antiviral agents (DAAs) are new drugs for the treatment of chronic hepatitis C virus (HCV) infection. These drugs are very effective and well tolerated. HCV can cause liver disease as well as extrahepatic manifestations, including a profound negative impact on …

il (code pays fourni par la source)

Thiopurine hepatotoxicity can mimic intrahepatic cholestasis of pregnancy

Roni Nasser, Daniel Kurnik, Yael Lurie, Laila Nassar et autres

il (code pays fourni par la source)